Reproductive Autonomy and Regulation-Coexistence in Action

Area of Science:

• Reproductive medicine
• Bioethics
• Health policy

Background:

• British IVF practitioners observe less regulation in US IVF and embryo research.
• A comparison is drawn between UK and US approaches to IVF and embryo research regulation.
• The perceived tension between regulation and autonomy in the US is contrasted with the UK perspective.

Purpose of the Study:

• To explore the implications of differing regulatory frameworks in IVF and embryo research between the UK and US.
• To question whether less regulation in the US leads to greater progress or reduced risk in IVF and embryo research.
• To advocate for the UK's regulatory model as a means to ensure patient safety and autonomy.

Main Methods:

• Comparative analysis of regulatory environments in the UK and US.
• Discussion of the philosophical underpinnings of regulation and autonomy.
• Personal experience from the former chair of the UK's Human Fertilisation and Embryology Authority (HFEA).

Main Results:

• The UK model, exemplified by the HFEA, demonstrates that regulation does not inherently conflict with autonomy.
• Regulation assures patient safety in assisted reproduction, similar to drug safety standards.
• A less regulated, market-driven field does not necessarily enhance autonomy for vulnerable patients.

Conclusions:

• Regulation in IVF and embryo research can coexist with and support patient autonomy.
• The UK's Human Fertilisation and Embryology Authority (HFEA) provides a model for safe and ethical practice.
• Patient safety and informed choice are better served through robust regulatory oversight rather than a less regulated market.